A functional polymorphism regulating dopamine β-hydroxylase influences against Parkinson's disease

被引：45

作者：

Healy, DG

Abou-Sleiman, PM

Ozawa, T

Lees, AJ

Bhatia, K

Ahmadi, KR

Wullner, U

Berciano, J

Moller, JC

Kamm, C

Burk, K

Barrone, P

Tolosa, E

Quinn, N

Goldstein, DB

Wood, NW

机构：

[1] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England

[2] Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England

[3] Univ London, Reta Lila Weston Inst Neurol Studies, London WC1E 7HU, England

[4] Univ Barcelona, Hosp Clin, Serv Neurol, Inst Clin Malaltias Sistema Nervios, Barcelona, Spain

[5] Univ Bonn, Dept Neurol, D-5300 Bonn, Germany

[6] Univ Hosp Marques de Valdecilla, Serv Neurol, Santander, Spain

[7] Univ Marburg, Dept Neurol, Marburg, Germany

[8] Univ Tubingen, Dept Neurodegenerat Dis, D-72074 Tubingen, Germany

[9] Univ Tubingen, Hertie Inst Clin Brain Res, D-72074 Tubingen, Germany

[10] Univ Tubingen, Dept Neurol, D-72074 Tubingen, Germany

[11] Univ Naples Federico 2, Dept Neurol Sci, Naples, Italy

[12] UCL, Dept Biol, London, England

来源：

ANNALS OF NEUROLOGY | 2004年 / 55卷 / 03期

关键词：

D O I：

10.1002/ana.20063

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

A functional -1021C --> T polymorphism in the dopamine beta-hydroxylase gene has been demonstrated to regulate plasma DBH activity. We report that individuals with genetically determined low serum DBH activity (genotype T/T) have protection against Parkinson's disease (p = 0.01). In particular, we observed an underrepresentation of the T/T genotype odds ratio = 0.46 (CI = 0.27-0.8). Rather than identifying a haplotype, or a marker in linkage disequilibrium with the risk variant, this to our knowledge is the first report directly linking PD susceptibility with a proven functional variant.

引用

页码：443 / 446

页数：4

共 15 条

[1] Genome-wide scan for Parkinson's disease:: The GenePD study
DeStefano, AL
Golbe, LI
Mark, MH
Lazzarini, AM
Maher, NE
Saint-Hilaire, M
Feldman, RG
Guttman, M
Watts, RL
Suchowersky, O
Lafontaine, AL
Labelle, N
Lew, MF
Waters, CH
Growdon, JH
Singer, C
Currie, LJ
Wooten, GF
Vieregge, P
Pramstaller, PP
Klein, C
Hubble, JP
Stacy, M
Montgomery, E
MacDonald, ME
Gusella, JF
Myers, RH
[J]. NEUROLOGY, 2001, 57 (06) : 1124 - 1126
[2] THE RELEVANCE OF THE LEWY BODY TO THE PATHOGENESIS OF IDIOPATHIC PARKINSONS-DISEASE
GIBB, WRG
LEES, AJ
[J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1988, 51 (06) : 745 - 752
[3] Pharmacogenomic analysis of mechanisms mediating ethanol regulation of dopamine β-hydroxylase
Hassan, S
Duong, B
Kim, KS
Miles, MF
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (40) : 38860 - 38869
[4] ACCURACY OF CLINICAL-DIAGNOSIS OF IDIOPATHIC PARKINSONS-DISEASE - A CLINICOPATHOLOGICAL STUDY OF 100 CASES
HUGHES, AJ
DANIEL, SE
KILFORD, L
LEES, AJ
[J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1992, 55 (03) : 181 - 184
[5] CSF DOPAMINE-BETA-HYDROXYLASE ACTIVITY IN PARKINSONS-DISEASE
HURST, JH
LEWITT, PA
BURNS, RS
FOSTER, NL
LOVENBERG, W
[J]. NEUROLOGY, 1985, 35 (04) : 565 - 568
[6] Mutations in the dopamine β-hydroxylase gene are associated with human norepinephrine deficiency
Kim, CH
Zabetian, CP
Cubells, JF
Cho, S
Biaggioni, I
Cohen, BM
Robertson, D
Kim, KS
[J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 108 (02): : 140 - 147
[7] LIEBERMAN AN, 1972, LANCET, V1, P153
[8] Pathogenesis of Parkinson's disease:: Dopamine, vesicles and α-synuclein
Lotharius, J
Brundin, P
[J]. NATURE REVIEWS NEUROSCIENCE, 2002, 3 (12) : 932 - 942
[9] DOPAMINE-BETA-HYDROXYLASE IMMUNOREACTIVITY IN HUMAN CEREBROSPINAL-FLUID - PROPERTIES, RELATIONSHIP TO CENTRAL NORADRENERGIC NEURONAL-ACTIVITY AND VARIATION IN PARKINSONS-DISEASE AND CONGENITAL DOPAMINE-BETA-HYDROXYLASE DEFICIENCY
OCONNOR, DT
CERVENKA, JH
STONE, RA
LEVINE, GL
PARMER, RJ
FRANCOBOURLAND, RE
MADRAZO, I
LANGLAIS, PJ
ROBERTSON, D
BIAGGIONI, I
[J]. CLINICAL SCIENCE, 1994, 86 (02) : 149 - 158
[10] Up-regulation of tyrosine hydroxylase mRNA in a sub-population of A10 dopamine neurons in Parkinson's disease
Tong, ZY
Kingsbury, AE
Foster, OJF
[J]. MOLECULAR BRAIN RESEARCH, 2000, 79 (1-2): : 45 - 54

← 1 2 →